Bei der Evaluierung von Follistatin Online-Verkäufe für wissenschaftliche Zwecke benötigen Laborforscher verlässliche Bezugsquellen mit nachgewiesener Reinheit. Follistatin ist ein rekombinantes Glykoprotein, das primär als Myostatin- und Activin-Antagonist in vitro und in präklinischen Tiermodellen untersucht wird. Eine qualifizierte Beschaffung erfordert Chargen-zertifizierte RP-HPLC-, Massenspektrometrie- und Endotoxin-Analysen von ISO-17025-akkreditierten US-Laboren zur Gewährleistung reproduzierbarer Studienergebnisse.
Bei der Evaluierung von Follistatin Online-Verkäufe für wissenschaftliche Zwecke benötigen Laborforscher verlässliche Bezugsquellen mit nachgewiesener Reinheit. Follistatin ist ein rekombinantes Glykoprotein, das primär als Myostatin- und Activin-Antagonist in vitro und in präklinischen Tiermodellen untersucht wird. Eine qualifizierte Beschaffung erfordert Chargen-zertifizierte RP-HPLC-, Massenspektrometrie- und Endotoxin-Analysen von ISO-17025-akkreditierten US-Laboren zur Gewährleistung reproduzierbarer Studienergebnisse.
Follistatin (FST) is an autocrine, single-chain monomeric glycoprotein expressed in almost all tissues of higher vertebrates. Structurally, the precursor protein undergoes alternative splicing and post-translational modifications to yield distinct biological isoforms, most notably Follistatin-288 (FST-288), Follistatin-300 (FST-300), and Follistatin-315 (FST-315), as well as modified peptides like Follistatin-344. In structural biology, Follistatin is defined by its high-affinity binding to members of the transforming growth factor-beta (TGF-β) superfamily, specifically Activin A, Activin B, and Myostatin (Growth Differentiation Factor 8 / GDF-8).
The molecular architecture of Follistatin comprises an N-terminal domain followed by three conserved Follistatin domains (FS1, FS2, and FS3). Each FS domain contains a Kazal-like motif that participates in protein-protein interactions. When Follistatin binds to Activin or Myostatin, two Follistatin molecules wrap around the dimeric ligand, effectively neutralizing its ability to engage cell-surface serine/threonine kinase receptors such as ActRIIA and ActRIIB. For research institutions analyzing muscle hypertrophy, cellular signaling cascades, and tissue remodeling, obtaining authentic material via legitimate research peptides channels is critical to eliminating confounding biochemical variables.
When procurement departments and academic laboratories evaluate search terms like 'follistatin online-verkäufe', the primary operational risk revolves around reagent quality, structural fidelity, and contamination. Glycoproteins such as Follistatin present unique synthetic and recombinant challenges compared to short linear peptides. Expression in eukaryotic or prokaryotic systems requires rigorous refolding protocols, precise disulfide bond pairing, and stringent purification pathways to yield biologically active proteins.
Substandard commercial offerings frequently suffer from batch-to-batch variation, partial denaturation, high endotoxin levels, or mislabeled protein sequences. PX1 Research mitigates these risks by producing all research compounds within state-of-the-art, GMP-compliant facilities located in the USA. Every lot of our Follistatin 344 undergoes exhaustive analytical validation prior to release, ensuring that researchers receive highly purified, structurally consistent reagents for controlled in vitro and animal models.
In preclinical literature, Follistatin is most frequently studied for its capacity to downregulate the canonical Smad2/3 signaling axis downstream of ActRIIB activation. Under physiological conditions, Myostatin binds ActRIIB, initiating intracellular phosphorylation of Smad2 and Smad3. This complex translocates to the nucleus, upregulating E3 ubiquitin ligases (such as MuRF1 and MAFbx) and suppressing Akt/mTOR signaling, which suppresses protein synthesis and promotes muscle catabolism.
In vitro assays and rodent models demonstrate that recombinant Follistatin sequesters free extracellular Myostatin, preventing receptor dimerization and downstream Smad activation. Consequently, preclinical observations in murine models exhibit pronounced skeletal muscle hypertrophy, suppressed muscular atrophy, and altered adipose-to-lean mass ratios. Researchers accessing our comprehensive research hub can review published biochemical datasets detailing how targeted TGF-β inhibition alters downstream gene expression profiles across diverse cell lines.
To ensure high experimental reproducibility, laboratories must mandate strict analytical verification before integrating any purchased compound into active research protocols. High-Performance Liquid Chromatography (RP-HPLC) and Electrospray Ionization Mass Spectrometry (ESI-MS) serve as the gold standard dual-verification methodology for verifying peptide identity and purity.
RP-HPLC measures the chromatographic purity of the sample by separating components based on hydrophobic interactions, establishing that total peak area attributed to the target molecule exceeds 98.0%. ESI-MS confirms the exact molecular mass, verifying correct amino acid sequencing and absence of truncated side-products. At PX1 Research, every product batch is verified by an independent, ISO 17025-accredited laboratory, and a lot-specific Certificate of Analysis (COA) is made publicly available for complete experimental transparency.
Endotoxins—lipopolysaccharides (LPS) derived from the outer membrane of Gram-negative bacteria—represent a severe confounding variable in cell culture and animal research. When recombinant proteins are synthesized in bacterial expression systems like E. coli, residual LPS can trigger non-specific inflammatory signaling, Toll-like receptor 4 (TLR4) activation, cytokine release, and premature cell death in vitro.
To protect the integrity of delicate cell assays and microvascular rodent studies, research reagents must adhere to strict endotoxin thresholds (typically <0.1 EU/µg of protein). PX1 Research implements rigorous Limulus Amebocyte Lysate (LAL) testing protocols across all product runs. Laboratories purchasing through our wholesale platform receive verified, endotoxin-tested reagents suitable for high-sensitivity biochemical assays.
When designing comparative preclinical trials targeting anabolic signaling, metabolic homeostasis, or tissue regeneration, investigators frequently evaluate Follistatin alongside other peptides targeting similar physiological pathways. Understanding the mechanical differences between these agents is necessary for structured hypothesis testing.
For instance, while Follistatin functions primarily as an extracellular ligand trap for Myostatin and Activin, compounds such as IGF-1 LR3 stimulate hyperplastic and hypertrophic pathways directly through IGF-1R receptor autophosphorylation and the PI3K/Akt system. Similarly, MGF (Mechano Growth Factor) acts locally in response to mechanical overload to activate satellite cell proliferation, whereas growth hormone secretagogues like CJC-1295 influence systemic growth hormone pulsatility. Comparing these mechanisms within our guide on myostatin inhibitors highlights why Follistatin remains unique in its specific sequestration of negative growth factors.
Lyophilized proteins like Follistatin require strict adherence to reconstitution and storage procedures to maintain biological activity and prevent aggregation. Upon receipt, lyophilized vials should be stored at -20°C or -80°C for long-term stability, protected from direct light exposure and humidity fluctuations.
Reconstitution should be performed using sterile, laboratory-grade solvents such as Bacteriostatic Water (0.9% benzyl alcohol) or sterile phosphate-buffered saline (PBS, pH 7.4), depending on the requirements of downstream assays. Solvent should be allowed to run gently down the inner glass wall of the vial rather than sprayed directly onto the lyophilized cake. Gentle swirl agitation is recommended—vortexing must be strictly avoided, as mechanical shear forces can cause irreversible protein denaturation. For exact volumetric dilution calculations, researchers can reference our interactive peptide reconstitution calculator.
The global marketplace for analytical reagents features significant variability in quality standards. Overseas manufacturers often lack standardized quality management systems, leading to batch inconsistency, heavy metal contamination, and degraded peptide chains caused by uncontrolled transit conditions. Laboratories conducting high-impact research require domestic suppliers with transparent quality controls.
PX1 Research operates exclusively within the United States, utilizing GMP-compliant facilities in California and Arizona. Orders are fulfilled with same-day shipping (Monday through Friday), ensuring rapid transit times and minimal exposure to thermal degradation during transport. Each shipment includes full lot traceability, enabling research teams to correlate experimental outcomes directly with certified analytical testing documentation.
It is imperative for procurement officers, lab technicians, and principal investigators to maintain clear compliance boundaries regarding peptide sourcing. Follistatin, Follistatin-344, and related recombinant variants sold by PX1 Research are strictly designated for laboratory research use only (RUO). They are intended exclusively for in vitro diagnostic assays, structural modeling, binding affinity studies, and non-human animal research models.
These compounds are not approved by the U.S. Food and Drug Administration (FDA) or European Medicines Agency (EMA) for human consumption, therapeutic treatment, diagnostic administration, or clinical application. Explicit adherence to RUO guidelines ensures that research institutions maintain full ethical and regulatory compliance while contributing to fundamental scientific literature.
What is the specific target mechanism of Follistatin in preclinical models?
Follistatin functions primarily as a high-affinity antagonist to Activin A, Activin B, and Myostatin (GDF-8). By binding these TGF-β superfamily ligands extracellularly, Follistatin prevents them from interacting with ActRIIA/ActRIIB receptors, thereby blocking downstream Smad2/3 phosphorylation and catabolic gene expression.
Why is third-party COA verification critical when reviewing follistatin online-verkäufe?
Third-party COAs generated by ISO 17025-accredited laboratories verify chemical identity via Mass Spectrometry (ESI-MS) and structural purity via RP-HPLC (>98%). This eliminates risks associated with truncated peptides, unreactive precursors, host-cell proteins, and endotoxin contamination.
How should lyophilized Follistatin be stored upon delivery?
Lyophilized Follistatin should be stored at -20°C to -80°C in a desiccated environment. Reconstituted solutions should be aliquoted to avoid freeze-thaw cycles and stored at 4°C for short-term use (up to 7 days) or -80°C for long-term storage.
What solvent is recommended for reconstituting recombinant Follistatin for in vitro assays?
Depending on cellular toxicity constraints, reconstitution is typically performed using sterile Bacteriostatic Water or sterile PBS (pH 7.4). Avoid high-shear agitation or vortexing during solubilization to preserve tertiary protein structure.
What are the acceptable endotoxin thresholds for research-grade Follistatin?
For reliable in vitro and preclinical animal research, endotoxin levels should ideally test below 0.1 EU/µg of protein using standard LAL assays to prevent non-specific immune signaling or cytotoxicity.
How does Follistatin-344 differ structurally from native Follistatin-315?
Follistatin-344 is a precursor peptide sequence containing an extended C-terminal segment that is cleaved post-translationally in vivo to yield circulating FST-315. In research settings, FST-344 recombinant formats are used to evaluate local tissue retention and binding kinetics.
Where are PX1 Research compounds manufactured and shipped from?
All PX1 Research compounds are manufactured in USA-based, GMP-compliant facilities and shipped directly from fulfillment centers in California and Arizona with same-day shipping on orders placed Monday through Friday.
Are PX1 Research peptides approved for human administration?
No. All products offered by PX1 Research are strictly for in vitro, cell culture, and laboratory animal research use only. They are explicitly not for human use, therapeutic administration, or clinical trial applications.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.